SNYDER, LINDA,MANTHEY, CARL L.,DE BOER, CARLA,ELSAYED, YUSRI A.,KHAN, IMRAN
申请号：
MX2015012344
公开号：
MX2015012344A
申请日:
2014.03.13
申请国别(地区):
MX
年份:
2016
代理人:
摘要：
The present invention is directed to methods for the treatment of Hodgkins lymphoma comprising administering to a patient in need thereof, a therapeutically effective amount of 4-cyano-N-(2-(4,4-dimethylcyclohex-1-en-1-yl)-6-(2,2,6,6-tetram ethyltetrahydro-2H-pyran-4-yl)pyridin-3-yl)-1H-imidazole-2-carbo xamide as mono-therapy or as combination or co-therapy with one or more chemotherapeutic agent or chemotherapy regimens.La presente invención se dirige a métodos para el tratamiento de linfoma de Hodgkin que comprende administrar a un paciente que lo necesite, una cantidad terapéuticamente eficaz de 4-ciano-N-(2-(4,4-dimetilciclohex-1-en-1-iI)-6-(2,2,6,6-tetrameti ltetrahidro-2H-piran-4-il)piridin-3-il)-1H-imidazola-2-carboxamid a, como monoterapia o como combinación o coterapia con uno o más agentes quimioterapéuticos o régimen de quimioterapia.
